CureTech Innovative Therapies
Spencer Dohrman is an accomplished professional with a diverse background in strategic growth, sales management, and education. Currently serving as the Director of Strategic Growth at CureTech Innovative Therapies since April 2024, Spencer emphasizes revenue growth, market expansion, and customer relationship enhancement through data-driven strategies. Previous roles include Territory Sales Manager at TIDI Products, Connected Care Account Manager at Philips, and various sales and account management positions at Fisher & Paykel Healthcare and Bioventus. Spencer’s educational background encompasses multiple degrees in architecture and marine sciences from esteemed institutions, complemented by early experience as a teaching assistant and a graphic and video designer.
This person is not in any teams
CureTech Innovative Therapies
The market leader of mobile DVT Prevention and Cryo-Compression solutions. With a mission to improve patient outcomes and provider satisfaction scores, CureTech's customizable ASC/Clinic programs quickly became physician's #1 choice for post-op recovery & preventative therapies. With the belief that healthcare needed to be reimagined, CureTech was created. CureTech believes that the “patient experience” starts first by creating the perfect “rep experience”. By focusing on our people, with a shared passion of changing the patient experience after surgical intervention. By focusing on patient satisfaction, preventing post surgical complications, alleviating opioids, and accelerating recovery, CureTech’s vision came to life in large part to our amazing physicians, ASCs, and coast-to-coast distributor partners! In short time, CureTech has become one the nation’s largest and most trusted Durable Medical Equipment (DME) suppliers with representation in 32 states. Offices located in Kentucky, Tennessee and Texas. Awarded: 2024 Best Places to Work 2023 #1 Supplier of the Year 2022 #2 Fastest Growing Company, KY 2022 #1 Supplier of the Year